Giving oral Cabergoline or calcium infusion in women at high risk for developing ovarian hyperstimulation syndrome in context of assisted reproductive technologies aiming in its prevention
Women undergoing in vitro fertilization or intracytoplasmic sperm injection whom were at high risk for developing ovarian hyperstimuation syndrome were received either oral Cabergoline.5mg tablets for 7days starting on ovum pick up day and continued for 7days or received 10ml of 10%calcium gluconate in 200ml normal saline on ovum pick up day and continued for 4days
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
230
Giving oral Cabergoline tablet 0.5 milligram daily starting on ovum pick up day and continued for seven days
Giving 10 ml of 10 % calcium gluconate on 200 ml normal saline solution o.9% intravenously over thirty minutes starting on ovum pick up day and continued for four days
Ashraf nassif Elmantwe
Cairo, Elqalopia, Egypt
Occurrence of ovarian hyperstimuation syndrome
Clinical condition occurred in context of assisted reproductive technologies in which there serous sacs fluid accumulation and hemoconcentration
Time frame: 20 days from ovum pick up day
Types of ovarian hyperstimuation syndrome and severity
Clinical severity either mild ,moderate or severe and its type either early or late onst
Time frame: 20 days from ovum pick up day
Chemical pregnancy
Positive human chorionic Gonadotropin in blood
Time frame: 14 day from embryos transfer day
Clinical pregnancy
Intrauterine gestational sac
Time frame: 5 week from embryos transfer day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.